← All Sponsors
SPONSOR

University of Oklahoma

Total Trials
15
Recruiting
15
Phases
Phase 2, Phase 1, Phase 4, Phase 3

University of Oklahoma is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including CRC Screening, CRC (Colorectal Cancer), Alcohol Drinking, Heavy Drinking.

The trial portfolio spans Phase 2, Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Oklahoma

How many clinical trials has University of Oklahoma sponsored?
ClinicalMetric currently tracks 15 clinical trials sponsored by University of Oklahoma, of which 15 are actively recruiting participants. These trials cover conditions including CRC Screening, CRC (Colorectal Cancer), Alcohol Drinking. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Oklahoma research focus on?
University of Oklahoma clinical trials span CRC Screening, CRC (Colorectal Cancer), Alcohol Drinking, Heavy Drinking, Binge Drinking, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Oklahoma clinical trial?
To participate in a University of Oklahoma trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Oklahoma trials with current recruitment status updated daily.

Clinical Trials by University of Oklahoma

NCT07254910
Recruiting

Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma

CRC Screening
NCT07591428
Recruiting

Reset Challenge: Reducing High-risk Drinking for Cancer Prevention

Alcohol Drinking
NCT05233228 Phase 2
Recruiting

Mobile Health Technology for Personalized Tobacco Cessation Support in Laos

Cigarette Smoking
NCT06130995 Phase 1
Recruiting

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Androgen Deprivation Therapy
NCT07554118
Recruiting

Postural Control in Adults

Older
NCT05723081
Recruiting

Oklahoma Study of Native American Pain Risk III: Stress and Resilience

Discrimination, Racial
NCT06725953
Recruiting

Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 Diabetes

Cancer Survivorship
NCT07701304
Recruiting

Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment

Cannabis Use
NCT05052671
Recruiting

ctDNA Assay in Patients With Resectable Pancreatic Cancer

Pancreas Cancer
NCT07223541 Phase 2
Recruiting

Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma
NCT06651359
Recruiting

Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors

Prostate Cancer
NCT07014618
Recruiting

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

Breast Cancer
NCT05176379 Phase 4
Recruiting

Endothelial Derived Hyperpolarization Factor and Vascular Control

Healthy
NCT04459000
Recruiting

Substance Use Treatment and Access to Resources (STARS) Project

Substance Use Disorders
NCT05174052 Phase 3
Recruiting

Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)

Diabetes Mellitus
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology